Evidence map›Paper›PMID 28376888›Full record

ArticleBMC complementary and alternative medicine2017

Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice.

Hironori Fujiwara, Yaoyu Han, Ken Ebihara, Suresh Awale, Ryota Araki, Takeshi Yabe, Kinzo Matsumoto

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Autism Spectrum Disorder-Related Syndromes: Modeling withInternational journal of molecular sciences · 2019
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hironori FujiwaraDivision of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama, Toyama, Japan. arawijuf@inm.u-toyama.ac.jp.
Yaoyu HanDivision of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Ken EbiharaDivision of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Suresh AwaleDivision of Natural Drug Discovery, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Ryota ArakiLaboratory of Functional Biomolecules and Chemical Pharmacology, Faculty of pharmaceutical sciences, Setsunan University, Osaka, Japan.
Takeshi YabeLaboratory of Functional Biomolecules and Chemical Pharmacology, Faculty of pharmaceutical sciences, Setsunan University, Osaka, Japan.
Kinzo MatsumotoDivision of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama, Toyama, Japan. mkinzo@inm.u-toyama.ac.jp.
University of Toyama · JPSetsunan University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur previous studies demonstrated that post-weaning social isolation (ISO) in mice induces behavior abnormalities such as deficits of sociability- and attention-like behaviors. These deficits can be attenuated by methylphenidate (MPH), a drug used for attention deficit hyperactivity disorder (ADHD), suggesting that ISO mice offer a potential animal model of comorbid developmental disorder with ADHD and autism spectrum disorder symptoms. This study investigated the effects of Kampo formulae, yokukansan (YKS) and keishito (KST), on the neuropsychiatric symptoms of ISO mice to clarify the therapeutic or preventive/delaying potential of these formulae for the treatment of neurodevelopmental disorders.

methodsThree-to-4-week old male ICR mice were socially isolated during an experimental period and YKS and KST (1523.6 and 2031.8 mg/kg, p.o.) was administered starting from week 2 and week 0 after starting ISO for the analysis of their therapeutic and preventive/delaying potentials, respectively. Sociability, attention-related behavior and fear memory were elucidated by a 3 chamber test, a water-finding test and fear conditioning test, respectively. Moreover, the phosphorylation of neuroplasticity-related signaling molecules in mice hippocampus was analyzed using western blotting.

resultsIn a therapeutic procedure, YKS ameliorated ISO-induced impairments of attention-like behavior and context-dependent fear memory, but not of sociability, whereas KST had no beneficial effects in ISO mice. In experiments to analyze the preventive/delaying potentials of these treatments, both YKS and KST improved sociability, attention, and context-dependent fear memory deficits. The improvement of sociability in mice by YKS and KST was not inhibited by a dopamine D

conclusionsThese findings suggest that YKS and KST may be useful for the improvement of neurodevelopmental disorders.

Indexed as

Social IsolationAnimalsBehavior, AnimalDown-RegulationDrugs, Chinese HerbalMaleMedicine, KampoMiceMice, Inbred ICRNeuronal PlasticityPhosphorylationSignal TransductionDrugs, Chinese Herbalkeishi-toYi-Gan SanAttention deficit hyperactivity disorderDevelopmental disordersKampo formulaeKeishitoSocial isolationYokukansan

Identifiers

PMID28376888
PMCPMC5379572
OpenAlexW2604249621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.